Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

The XEC COVID-19 variant is poised to become the dominant variant worldwide. Now is a good time to get an updated COVID ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 ...

Northeastern University professors of pharmacy say the updated COVID-19 vaccines available for fall and winter of 2024 are a ...

The report, riddled with lies and misinformation, is a crude justification for the subordination of public health and lives ...

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for ...

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

An abundance of evidence indicates the mRNA COVID-19 vaccines are remarkably safe and work well to protect against severe ...

This year’s COVID-19 booster was rolled out in doctors offices and pharmacies in September, and attempts to address the rise ...